Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depression (TRD) ...
Is Compass Minerals International, Inc. (CMP) a buy, sell, or hold? 4 analysts have issued ratings. Wall Street analysts rate CMP as Bullish on average, for a Wall Street consensus of buy. View CMP’s ...
Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results